This blog continues to point to the bizarre acceptance of ISO laboratory accreditation by clinicians who should know better. Where there’s little evidence – and it’s weak – don’t use the treatment! This would be true even if it wasn’t as expensive as accreditation which increases costs by over a third.
Below is a helpful graphic from new American Heart Association and American Stroke Association guidelines. If you’re pushed for time, start at the bottom right. That’s where the strength of evidence for ISO accreditation is described. Does it rise above the red band? Red for danger.
After all the years of demanding evidence of continual improvement from their victims the cartel members haven’t made much progress up this matrix of evidence for their own extortion business.